about
Modelling of the cancer cell cycle as a tool for rational drug development: A systems pharmacology approach to cyclotherapy.Targeting melanoma's MCL1 bias unleashes the apoptotic potential of BRAF and ERK1/2 pathway inhibitorsMulticenter Validation of the CamGFR Model for Estimated Glomerular Filtration RateEarly relapse on adjuvant gemcitabine associated with an exceptional response to 2nd line capecitabine chemotherapy in a patient with pancreatic adenosquamous carcinoma with strong intra-tumoural expression of cytidine deaminase: a case reportLoss of the interleukin-6 receptor causes immunodeficiency, atopy, and abnormal inflammatory responses
P50
description
researcher
@en
wetenschapper
@nl
name
Duncan I Jodrell
@en
Duncan I Jodrell
@nl
type
label
Duncan I Jodrell
@en
Duncan I Jodrell
@nl
prefLabel
Duncan I Jodrell
@en
Duncan I Jodrell
@nl
P31
P496
0000-0001-9360-1670